Warning
ONESOURCE SPECIALTY PHARMA LIMITED Recalls Methohexital Sodium for Injection
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0662-2026Drug / Pharmaceutical
ONESOURCE SPECIALTY PHARMA LIMITED Recalls Methohexital Sodium for Injection
ONESOURCE SPECIALTY PHARMA LIMITED · Class II — Moderate Risk
Product Description
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Reason for Recall
Failed Impurities/Degradation Specifications
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the United States
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
ONESOURCE SPECIALTY PHARMA LIMITED has recalled a pharmaceutical product that the FDA classified as Class II affecting 4284 vials. The recall was initiated on June 7, 2026. Failed Impurities/Degradation Specifications. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.